DR

Divyakolu Ramanjaneyulu

Active Director Additional Director DIN 08101455
DIN 08101455 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 2018
Shareholding value •••• Premium profile

About Divyakolu Ramanjaneyulu

Data last updated:

Divyakolu Ramanjaneyulu is an Additional Director at Okinawa Pharmaceuticals Private Limited (since 2024), Director at Italian Remedies Private Limited (since 2024) and Director at Vande Bharat Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma, Financial Services and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹14.27 Cr; the largest is Okinawa Pharmaceuticals Private Limited at ₹14.10 Cr (FY 2025). Earlier, Divyakolu Ramanjaneyulu was a Director at Leogenic Healthcare Private Limited (2018–2020) and Director at Leogenic Pharma Private Limited (2018–2020).

DIN 08101455
Primary Designation Additional Director
Industry Pharma
First Appointment 03 Apr 2018
Oldest Company Age 10 yrs
Largest company Okinawa Pharmaceuticals Private Limited · ₹14.10 Cr (FY 2025)
Combined revenue ₹14.27 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director04 Apr 20242015₹14.10 Cr (FY 2025)Active
Italian Remedies Private Limited U65929TG2021PTC147555
Director24 Feb 20242021₹17.6 Lakh (FY 2025)Active
Director29 Jan 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Leogenic Healthcare Private Limited U85320MH2018PTC308093
Director16 Apr 20182018₹5.93 Cr (FY 2020)Active
Leogenic Pharma Private Limited U24304TG2018PTC123511
Director03 Apr 20182018₹5,000 (FY 2019)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vande Bharat Pharmaceuticals Private Limited
Italian Remedies Private Limited
Okinawa Pharmaceuticals Private Limited
Leogenic Healthcare Private Limited
Premium access

Shareholding and investment profile for Divyakolu Ramanjaneyulu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Divyakolu Ramanjaneyulu

Divyakolu Ramanjaneyulu currently holds 3 directorships: Okinawa Pharmaceuticals Private Limited (Additional Director, since 04 Apr 2024, revenue ₹14.10 Cr (FY 2025)); Italian Remedies Private Limited (Director, since 24 Feb 2024, revenue ₹17.6 Lakh (FY 2025)); Vande Bharat Pharmaceuticals Private Limited (Director, since 29 Jan 2025).

Divyakolu Ramanjaneyulu was first appointed on 03 Apr 2018 as Director at Leogenic Pharma Private Limited. The most recent appointment on record is 29 Jan 2025 at Vande Bharat Pharmaceuticals Private Limited.

The 2 current companies of Divyakolu Ramanjaneyulu that report revenue have a combined latest revenue of ₹14.27 Cr: Okinawa Pharmaceuticals Private Limited ₹14.10 Cr (FY 2025); Italian Remedies Private Limited ₹17.6 Lakh (FY 2025).

Divyakolu Ramanjaneyulu held 2 earlier board appointments: Leogenic Healthcare Private Limited (Director, 16 Apr 2018 to 25 Jun 2020); Leogenic Pharma Private Limited (Director, 03 Apr 2018 to 25 Jun 2020).

The current boards of Divyakolu Ramanjaneyulu's companies include Anjaneyulu Boddapati (Okinawa Pharmaceuticals Private Limited), Chandra Sekhara Reddy Eduru (Okinawa Pharmaceuticals Private Limited), Ramadevi Ananthu (Okinawa Pharmaceuticals Private Limited), Srujana Bitra (Okinawa Pharmaceuticals Private Limited), Venkatrao Mandati (Okinawa Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available